Amryt Pharma plc (LON:AMYT – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 143 ($1.87) and traded as high as GBX 155 ($2.02). Amryt Pharma shares last traded at GBX 143 ($1.87), with a volume of 90,726 shares traded.
Amryt Pharma Stock Performance
The company has a quick ratio of 1.14, a current ratio of 1.80 and a debt-to-equity ratio of 66.05. The firm has a 50-day moving average price of GBX 143 and a 200 day moving average price of GBX 143. The firm has a market capitalization of £457.11 million and a PE ratio of -4.33.
About Amryt Pharma
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Recommended Stories
- Five stocks we like better than Amryt Pharma
- NYSE Stocks Give Investors a Variety of Quality Options
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What Are Some of the Best Large-Cap Stocks to Buy?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
